Juvelook Treatment in London

Visible changes in skin texture, hydration, and resilience often reflect a gradual decline in natural collagen activity beneath the surface. Juvelook addresses these concerns by combining hyaluronic acid with PDLLA microspheres to support the skin’s own regenerative processes, aiming to improve quality, smoothness, and overall skin health over time.

As a skin booster with collagen-stimulating properties, Juvelook is suited to patients who notice fine lines, dullness, uneven texture, or early laxity, and who prefer a gradual, biologically led approach to rejuvenation. For those exploring Juvelook London options, the emphasis at this clinic is on measured, evidence-conscious treatment planning rather than trend-led intervention.

Consultation and Pricing

Treatment suitability, the personalised plan, and final cost are confirmed after consultation and clinical assessment, reflecting anatomy, product volume, treatment scope, session count, and complexity.

The figures below represent general London market guidance only, based on publicly advertised prices reviewed in June 2026 across 10 London clinics. These are not our clinic’s prices and may not account for consultation fees, promotional pricing, product volume differences, technique variation, or individual treatment planning.

London market guide — Juvelook Treatment

  • Per session (single area): about £250–£450
  • Per session (full face): about £350–£600
  • Under-eye treatment per session: about £300–£500
  • Course of 3 sessions: about £750–£1,500
  • Juvelook Volume (Lenisna) per session: about £350–£600

Before and After Juvelook Treatment

In the weeks following treatment, patients commonly notice improvements in skin hydration, surface smoothness, and overall radiance. Fine lines may appear gradually softened as collagen activity progresses within the dermis, with visible changes typically becoming more apparent two to four weeks after the initial session.

Greater improvements in firmness and elasticity tend to develop progressively across a course of sessions. Skin often takes on a more rested, naturally renewed appearance rather than an immediately treated look, which reflects the regenerative character of Juvelook’s collagen stimulation mechanism.

Visible improvements patients commonly report:

  • Improved skin texture and a smoother, more even surface
  • Enhanced hydration and a more radiant, refreshed complexion
  • Gradual softening of fine lines and surface irregularities
  • Progressive improvement in elasticity and skin firmness over time

What is Juvelook?

Juvelook is an injectable skin booster formulated from poly-D,L-lactic acid (PDLLA) microspheres and non-crosslinked hyaluronic acid. The PDLLA component acts as a collagen-stimulating scaffold, while the hyaluronic acid provides immediate hydration and surface improvement.

Unlike traditional fillers, which act primarily by adding gel volume, Juvelook works at a cellular level to support natural collagen renewal and improve skin quality from within. The formulation is applied superficially into the dermis, making it particularly suited to delicate areas such as under-eye skin, where heavier products may not be appropriate.

Its dual-action profile — immediate hydration alongside progressive collagen stimulation — distinguishes Juvelook from conventional hyaluronic acid skin boosters. The PDLLA microspheres degrade gradually, encouraging fibroblast activity and supporting the formation of new collagen and elastin over the weeks that follow.

Key characteristics of Juvelook:

  • Combines PDLLA microspheres with non-crosslinked hyaluronic acid
  • Designed to improve skin texture, hydration, and skin firmness through collagen stimulation
  • Suitable for delicate and thin skin areas, including under-eye and perioral zones
  • Applied via fine needle injection into the superficial to mid-dermis
  • Distinct from traditional fillers — aims to enhance skin quality rather than add structural volume

The Juvelook Treatment Process: Step by Step

01.

Initial Consultation

A face-to-face consultation explores your skin concerns, treatment goals, relevant medical history, and suitability for Juvelook as a skin booster. Where prescription products are required, Dr. Ivan provides this assessment.

02.

Clinical Assessment and Treatment Planning

The treatment area is assessed for skin quality, texture, thickness, and prior treatment history. A personalised treatment plan is prepared, confirming session count, product selection, and injection approach.

03.

Pre-Treatment Preparation

The skin is cleansed, and a topical anaesthetic is applied to the treatment area in advance to minimise procedural discomfort during injection.

04.

Treatment Delivery

Juvelook is delivered via fine needle micro-injection across the treatment area using a controlled, structured injection technique. Sessions typically take between 30 and 45 minutes.

05.

Aftercare and Recovery Guidance

Aftercare instructions are provided at the end of each session to support recovery and optimise outcomes across the days that follow.

Procedure time: 30–45 minutes

Recovery: Minimal downtime is typical. Mild redness, small injection-site bumps, or localised sensitivity generally resolve within 24 to 48 hours.

Benefits of Juvelook

Juvelook offers a targeted approach to skin quality improvement, aiming to address the underlying decline in collagen activity that contributes to visible ageing rather than producing surface change alone. Its capacity to improve hydration, texture, and skin firmness makes it appropriate for a wide range of concerns across different skin types.

For patients experiencing fine lines, enlarged pores, acne scars, or early laxity, Juvelook may provide progressive improvement through structured course-based treatment. Results accumulate over the weeks following each session, with the most significant changes typically observed following a full course of two to three sessions spaced several weeks apart.

Its suitability for delicate zones — particularly around the eyes and areas of thin skin — extends its clinical utility beyond what traditional fillers can appropriately address. Patients commonly pursue Juvelook as part of a broader skin rejuvenation plan or as a preventative measure during earlier stages of visible collagen decline.

Key benefits of Juvelook treatment:

  • May help improve skin texture, smoothness, and surface evenness
  • Aims to support collagen and elastin production within the dermis
  • Can contribute to improved hydration, luminosity, and radiant skin quality
  • Suitable for delicate areas where traditional fillers may not be appropriate
  • May improve the appearance of acne scars and uneven post-inflammatory skin
  • Compatible with Juvelook and Lenisna protocols for enhanced regeneration across multiple depths
  • Progressive, naturally refined outcomes suited to long-term skin health planning

Juvelook Treatment Options

Option One: Targeted Single-Area Skin Booster

A focused Juvelook treatment addressing a localised concern such as under-eye skin quality, perioral fine lines, or isolated texture irregularity. Delivered in a single session with reassessment to determine whether further injections are warranted based on the skin’s response and individual goals.

Option Two: Full-Face Collagen Stimulation Course

A comprehensive Juvelook treatment protocol addressing diffuse collagen decline, widespread dullness, and generalised texture or skin firmness concerns across the full face. Structured as a course of two to three sessions spaced several weeks apart to allow progressive collagen stimulation to develop.

Option Three: Juvelook and Lenisna Combined Protocol

An advanced regenerative approach pairing Juvelook with Juvelook Volume (Lenisna) to address skin quality and mild volume loss across multiple tissue depths. Appropriate for patients with more established laxity or those seeking a more comprehensive collagen renewal outcome through a dual-formulation plan.

Summary of available treatment approaches:

  • Single-area Juvelook injection for targeted concerns, including under-eye treatment
  • Full-face Juvelook skin booster course for diffuse collagen decline
  • Juvelook and Lenisna combined protocol for multi-depth regeneration
  • Course-based planning for patients requiring multiple sessions to reach treatment goals
  • Juvelook is often integrated into broader skin rejuvenation programmes alongside other aesthetic treatments

Why Choose Us?

Angelika brings over eight years of international medical experience to every treatment, combining advanced technique with a structured commitment to individual patient assessment and evidence-based care.

Her practice is guided by UK certification and insurance standards, with a focus on subtle, carefully considered outcomes that reflect each patient’s anatomy and skin health rather than a fixed procedural template.

Where prescription-only injectable products are required, GMC-registered prescriber Dr. Ivan provides the necessary face-to-face consultation and clinical prescribing, ensuring full regulatory compliance at every stage.

Every Juvelook treatment plan is built from individual clinical assessment, tailored to skin type, concerns, treatment history, and realistic goals. Patients at this central London clinic benefit from consistent professional standards and access to ongoing review throughout their treatment journey.

What distinguishes our approach:

  • Over 8 years of international medical experience underpinning clinical technique
  • Advanced aesthetic practice aligned with UK certification, insurance, and safety standards
  • GMC-registered prescribing support from Dr. Ivan, where clinically required
  • Personalised Juvelook treatment planning confirmed through thorough clinical assessment
  • Evidence-based skin booster protocols with appropriate qualification of outcomes
  • Central London clinic environment with consistent professional standards throughout

Disclaimer: Angelika is an aesthetic practitioner, not a medical doctor. Where prescription-only products are clinically appropriate, face-to-face consultation and prescribing are provided by GMC-registered prescriber Dr. Ivan. This treatment is available to patients aged 18 and over.

FAQ

Frequently Asked Questions

Results vary between individuals depending on skin condition, age, lifestyle, and the number of sessions completed. Patients who undergo a full course frequently notice improvements in texture, hydration, and radiance persisting for several months following their final session. The collagen stimulation mechanism means benefits continue to develop after treatment ends. Maintenance sessions are commonly considered to sustain skin quality improvements over the longer term, with intervals determined during clinical review.

As with any injectable skin treatment, Juvelook carries potential risks and considerations that must be assessed before proceeding. These may include temporary redness, swelling, bruising, or small bumps at injection sites. More rarely, infection or uneven distribution can occur. Suitability is evaluated during a thorough face-to-face consultation, taking into account individual medical history, skin condition, and treatment goals. Every treatment carries considerations, and these are discussed openly prior to any session being carried out.

The appropriate session count depends on individual skin concerns, the degree of collagen decline, and the goals established during consultation. Many patients begin with a course of two to three sessions, typically spaced four to six weeks apart, to allow cumulative collagen stimulation to develop progressively. Milder concerns or patients at an earlier stage of ageing may respond well to a single session. A personalised treatment plan confirming frequency and spacing is provided following clinical assessment.

Most patients describe the experience as mild and generally well tolerated. A topical anaesthetic is applied in advance to minimise discomfort, and the fine needle injection technique used in Juvelook delivery aims to keep sensation manageable throughout. Brief stinging or pressure at injection sites may be noticed during the procedure. Discomfort typically resolves promptly once the session is complete, and any aftercare guidance will address sensitivity in the hours that follow.

Juvelook is generally associated with minimal downtime. Some patients notice mild redness, small raised bumps at injection sites, or localised sensitivity for 24 to 48 hours following treatment. These responses are typically transient and reflect normal tissue activity during the early phase of collagen stimulation. Detailed aftercare guidance is provided at the end of each session. Most individuals are able to resume their usual daily activities within a short period following their appointment.

Juvelook may be appropriate for adults experiencing early or progressive collagen decline, fine lines, dullness, uneven texture, enlarged pores, or areas of thin skin where traditional fillers are not suitable, including the under-eye area. It may also suit individuals seeking a preventative approach to skin quality at an earlier stage of visible ageing. Suitability is assessed based on skin condition, medical history, and treatment goals. Individuals who are pregnant, breastfeeding, or present with certain underlying conditions may not be suitable at this time.

Initial improvements in hydration and surface glow may be noticeable within the first one to two weeks following the first treatment session. Deeper collagen-led changes — including improvements in texture, skin firmness, and the appearance of fine lines — typically develop progressively over four to eight weeks. The full benefit from a complete course is generally most apparent approximately eight to twelve weeks after the final session, as new collagen continues to form within the dermis.

Juvelook is frequently planned alongside Juvelook Volume (Lenisna), where both skin quality and mild volume considerations are present. It may also be integrated into broader skin rejuvenation programmes alongside other aesthetic treatments, depending on individual assessment findings and clinical suitability. Timing and sequencing of any combined approach are considered carefully during consultation to avoid overlap or compromise of outcomes. Your practitioner will advise on the most appropriate plan for your specific concerns and goals at that stage.